SC-602
N/A
Report date: 2024/12/11 10:25:32
Base Information
Drug NameSC-602
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesInstitute of Immunology and Infection, Chinese Academy of Sciences ShanghaiWalter Reed Army Institute
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesWalter Reed Army InstituteInstitute of Immunology and Infection, Chinese Academy of Sciences Shanghai
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A